Cite
HARVARD Citation
Vela, C. et al. (2017). Quantitation of Targetable Somatic Mutations Among Patients Evaluated by a Personalized Medicine Clinical Service: Considerations for Off‐Label Drug Use. Pharmacotherapy. 37 (9), pp. 1043-1051. [Online].